Editor’s Choice: Soo Many Promising Results, Advancements and Treatment Options for the Rare Disease World!

TGIF Patient Worthians! This week we have promising results on promising results. First up is news on a Dravet syndrome treatment. Second is a Lupus Nephritis drug in the works! Third…

Continue Reading Editor’s Choice: Soo Many Promising Results, Advancements and Treatment Options for the Rare Disease World!
Promising Results from a Chronic Lymphocytic Leukemia Phase 2 Trial
https://pixabay.com/en/little-girl-praying-people-wishing-1894125/

Promising Results from a Chronic Lymphocytic Leukemia Phase 2 Trial

On June 21st, Targeted Oncology posted the results from a phase 2 clinical trial for chronic lymphocytic leukemia (CLL). The trial examined the effects of combing two therapies--obinutuzumab and bendamustine.…

Continue Reading Promising Results from a Chronic Lymphocytic Leukemia Phase 2 Trial
This Drug Could be a Second Chance at Renal Cell Carcinoma Remission
Source: https://pixabay.com/en/sunset-between-the-months-cancer-2350428/

This Drug Could be a Second Chance at Renal Cell Carcinoma Remission

Xynomic Pharma, a United States-based oncology research and development company, announced at the end of last month that it had entered into a partnership with the University of California San…

Continue Reading This Drug Could be a Second Chance at Renal Cell Carcinoma Remission